Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Nerve Block for Facial Muscle Reinnervation Study
NCT01833221Phase 4Terminated
- Sponsor
- CHU Caen Normandie
- Start
- Apr 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lidocaine in facial paralysis, sponsored by CHU Caen Normandie. Started Apr 2013; status: terminated.
02
Drugs
lidocaine
03
Conditions
facial paralysis
Beyond the preview
Go deeper on NCT01833221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01833221.